NASDAQ:ADMA

Adma Biologics Stock Insider Trading

Healthcare > Biotechnology

Buy ADMA

*Your capital is at risk

$8.69

+0.120 (+1.40%)

At Close: Jun 23, 2026

ADMA Biologics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -13.27. In total, the insiders bought 1.69M and sold 599.98K ADMA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-13.27
● Buy	1.69M shares
● Sell	599.98K shares
60% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Feb 09, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 27, 2026 Buy	Common Stock P-Purchase	Grossman Jerrold B Director	Director	6 400 Value: $50.6K
May 12, 2026 Buy	Common Stock P-Purchase	Grossman Jerrold B Director	Director	12 500 Value: $100.1K
May 11, 2026 Buy	Common Stock P-Purchase	Grossman Jerrold B Director	Director	12 500 Value: $100.1K
Apr 01, 2026 Sell	Common Stock F-InKind	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	20 362 Value: $185.5K
Mar 17, 2026 Sell	Common Stock G-Gift	Guiheen Lawrence P. Director	Director	30 000 Value: $0
Mar 17, 2026 Buy	Common Stock G-Gift	Guiheen Lawrence P. Director	Director	30 000 Value: $484.5K
Mar 16, 2026 Buy	Stock Option (right to buy) M-Exempt	Grossman Adam S President And CEO	CEO / President	15 000 Value: $81.0K
Mar 16, 2026 Sell	Common Stock S-Sale	Grossman Adam S President And CEO	CEO / President	6 000 Value: $91.0K
Mar 16, 2026 Sell	Common Stock S-Sale	Grossman Adam S President And CEO	CEO / President	15 000 Value: $227.4K
Mar 16, 2026 Buy	Common Stock M-Exempt	Grossman Adam S President And CEO	CEO / President	15 000 Value: $81.0K
Mar 13, 2026 Buy	Common Stock M-Exempt	Guiheen Lawrence P. Director	Director	30 000 Value: $109.8K
Mar 13, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Guiheen Lawrence P. Director	Director	30 000 Value: $109.8K
Mar 09, 2026 Buy	Stock Option (right to buy) M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	1 250 Value: $5K
Mar 09, 2026 Buy	Stock Option (right to buy) M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	1 525 Value: $4K
Mar 09, 2026 Buy	Stock Option (right to buy) M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	2 500 Value: $12.5K
Mar 09, 2026 Buy	Stock Option (right to buy) M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	2 646 Value: $7K
Mar 09, 2026 Buy	Stock Option (right to buy) M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	2 175 Value: $3K
Mar 09, 2026 Sell	Common Stock J-Other	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	91 266 Value: $0
Mar 09, 2026 Sell	Common Stock S-Sale	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	10 096 Value: $157.8K
Mar 09, 2026 Buy	Common Stock M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	2 500 Value: $12.5K
Mar 09, 2026 Buy	Common Stock M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	1 250 Value: $5K
Mar 09, 2026 Buy	Common Stock M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	2 646 Value: $7K
Mar 09, 2026 Buy	Common Stock M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	1 525 Value: $4K
Mar 09, 2026 Buy	Common Stock M-Exempt	Kestenberg-messina Kaitlin M. COO And SVP, Compliance	C-Suite Officer	2 175 Value: $3K
Mar 07, 2026 Sell	Common Stock F-InKind	Grossman Adam S President And CEO	CEO / President	29 513 Value: $454.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ADMA BIOLOGICS INC

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the ...

Read Full Profile Here